Xin Zhai

540 total citations
54 papers, 434 citations indexed

About

Xin Zhai is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Xin Zhai has authored 54 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 22 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Xin Zhai's work include Synthesis and biological activity (19 papers), Quinazolinone synthesis and applications (12 papers) and Cancer therapeutics and mechanisms (6 papers). Xin Zhai is often cited by papers focused on Synthesis and biological activity (19 papers), Quinazolinone synthesis and applications (12 papers) and Cancer therapeutics and mechanisms (6 papers). Xin Zhai collaborates with scholars based in China and United States. Xin Zhai's co-authors include Ping Gong, Nan Jiang, Ming Guo, Yanfang Zhao, Fang Jia, Yajing Liu, Tingting Zhang, Jun Liu, Yuxiang Chen and Yanfang Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Xin Zhai

51 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Zhai China 13 261 196 41 40 35 54 434
Gurmit Grewal United States 9 191 0.7× 222 1.1× 41 1.0× 15 0.4× 32 0.9× 14 361
Changkun Hu United States 10 414 1.6× 316 1.6× 82 2.0× 28 0.7× 35 1.0× 26 691
Yeh-Long Chen Taiwan 15 308 1.2× 278 1.4× 80 2.0× 20 0.5× 69 2.0× 23 568
Hidetoshi Shindoh United States 11 204 0.8× 265 1.4× 78 1.9× 24 0.6× 59 1.7× 17 568
Hiroo Koyama Japan 13 235 0.9× 252 1.3× 38 0.9× 22 0.6× 51 1.5× 28 547
Meining Wang China 10 168 0.6× 159 0.8× 56 1.4× 49 1.2× 22 0.6× 16 336
Gurubasavaraja Swamy Purawarga Matada India 16 332 1.3× 182 0.9× 114 2.8× 40 1.0× 31 0.9× 53 551
Rajesh Kakadiya Taiwan 16 506 1.9× 335 1.7× 86 2.1× 22 0.6× 35 1.0× 35 695
Carlos J. A. Ribeiro Portugal 13 230 0.9× 150 0.8× 65 1.6× 8 0.2× 26 0.7× 15 350

Countries citing papers authored by Xin Zhai

Since Specialization
Citations

This map shows the geographic impact of Xin Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Zhai more than expected).

Fields of papers citing papers by Xin Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Zhai. The network helps show where Xin Zhai may publish in the future.

Co-authorship network of co-authors of Xin Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Zhai. A scholar is included among the top collaborators of Xin Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Zhai. Xin Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Bing, et al.. (2025). Development of Tricyclic 4,5-Dihydro-3H-pyrrolo[2,3-c]quinolin-4-ones as Potent Autotaxin Inhibitors for Pulmonary Fibrosis Treatment In Vivo. Journal of Medicinal Chemistry. 68(7). 7476–7498. 2 indexed citations
2.
Liu, Nan, et al.. (2025). Structure-based identification of novel pyrrolo[2,3-d]pyrimidine analogs as potent autotaxin inhibitors. Journal of Molecular Structure. 1331. 141573–141573.
3.
4.
Wang, Wei, et al.. (2024). Discovery of a potent and selective JAK1-targeting PROTAC degrader with anti-tumor activities. Bioorganic & Medicinal Chemistry Letters. 109. 129838–129838. 5 indexed citations
5.
Zhang, Jiahao, et al.. (2024). A Collection of Novel Antitumor Agents That Regulate Lipid Metabolism in the Tumor Microenvironment. Journal of Medicinal Chemistry. 68(1). 49–80. 2 indexed citations
6.
Liu, Shuyu, et al.. (2024). Discovery of Novel Non-nucleoside DOT1LR231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy. Journal of Medicinal Chemistry. 67(18). 16248–16269. 1 indexed citations
7.
Zhang, Jiahao, et al.. (2024). Structure‐guided design of potent JAK1‐selective inhibitors based on 4‐amino‐7H‐pyrrolo[2,3‐d]pyrimidine with anti‐inflammatory efficacy. Archiv der Pharmazie. 357(4). e2300591–e2300591. 2 indexed citations
8.
9.
Zhang, Chao, Xiuyun Sun, Zhen Li, et al.. (2023). Photoredox-catalyzed reaction as a powerful tool for rapid natural product Gem-dimethylation modification: discovery of potent anti-cancer agents with improved druggability. SHILAP Revista de lepidopterología. 2(4). 3 indexed citations
10.
Chen, Yuxiang, et al.. (2022). Investigation of novel ATX inhibitor metabolites by UHPLC-orbitrap-MS/MS and molecular docking studies. Journal of Pharmaceutical and Biomedical Analysis. 211. 114606–114606. 1 indexed citations
11.
Long, Tengfei, Hao Zhang, Meng Li, et al.. (2021). Anti‐fibrosis attributes: UHPLC‐MS/MS‐based pharmacokinetics profiling of a novel autotaxin inhibitor with excellent in vivo efficacy in rat. Biomedical Chromatography. 36(4). e5301–e5301. 1 indexed citations
12.
Chen, Yuxiang, et al.. (2021). Design, synthesis and anti-fibrosis evaluation of imidazo[1,2–a]pyridine derivatives as potent ATX inhibitors. Bioorganic & Medicinal Chemistry. 46. 116362–116362. 3 indexed citations
13.
Guo, Ming, et al.. (2020). An updated patent review of autotaxin inhibitors (2017–present). Expert Opinion on Therapeutic Patents. 31(5). 421–434. 19 indexed citations
14.
Zang, Linghe, Fang Jia, Jie Wang, et al.. (2019). Design, synthesis and anti-inflammatory evaluation of novel pyrrolo[2,3-d]pyrimidin derivatives as potent JAK inhibitors. Bioorganic & Medicinal Chemistry. 27(18). 4089–4100. 11 indexed citations
15.
Jiang, Nan, Yuhong Zhou, Jun‐Long Zhang, et al.. (2019). Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis. European Journal of Medicinal Chemistry. 187. 111904–111904. 9 indexed citations
16.
Jiang, Nan, et al.. (2016). Design, Synthesis and Structure-Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors. Molecules. 21(11). 1572–1572. 19 indexed citations
17.
Zhai, Xin, et al.. (2012). Synthesis and cytotoxic activity of novel 2,6-disubstituted-4-mor-pholinothieno[3,2-d]pyrimidines as potent anti-tumor agents. Chinese Chemical Letters. 23(6). 703–706. 20 indexed citations
18.
Xie, Lijun, Yanfang Zhao, Xin Zhai, et al.. (2011). The Application of Tandem Aza‐Wittig Reaction to Synthesize Artemisinin–Guanidine Hybrids and Their Anti‐Tumor Activity. Archiv der Pharmazie. 344(10). 631–638. 17 indexed citations
19.
Xie, Lijun, Xin Zhai, Jian Zuo, Yanfang Zhao, & Ping Gong. (2010). (1R,3S,4R,4aS,7R,7aS,10R,12aR)-3-Azido-4,7,10-trimethyl-1,10-epidioxyperhydropyrano[4,3-j][1,2]benzodioxepine. Acta Crystallographica Section E Structure Reports Online. 66(7). o1839–o1839. 2 indexed citations
20.
Zhai, Xin, et al.. (2007). Synthesis and Anti‐Tumor Activities of a Novel Series of Tricyclic 1‐Anilino‐5H‐pyridazino[4,5‐b]indoles. Archiv der Pharmazie. 340(8). 424–428. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gurmit Grewal Breakdown of academic impact, for papers by Changkun Hu Breakdown of academic impact, for papers by Yeh-Long Chen Breakdown of academic impact, for papers by Hidetoshi Shindoh Breakdown of academic impact, for papers by Hiroo Koyama Breakdown of academic impact, for papers by Meining Wang Breakdown of academic impact, for papers by Gurubasavaraja Swamy Purawarga Matada Breakdown of academic impact, for papers by Rajesh Kakadiya Breakdown of academic impact, for papers by Carlos J. A. Ribeiro
Rankless by CCL
2026